- Company Overview for SHIRE PHARMACEUTICALS LIMITED (02031674)
- Filing history for SHIRE PHARMACEUTICALS LIMITED (02031674)
- People for SHIRE PHARMACEUTICALS LIMITED (02031674)
- Charges for SHIRE PHARMACEUTICALS LIMITED (02031674)
- Registers for SHIRE PHARMACEUTICALS LIMITED (02031674)
- More for SHIRE PHARMACEUTICALS LIMITED (02031674)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
18 Dec 2024 | AA | Full accounts made up to 31 March 2024 | |
02 Dec 2024 | AD03 | Register(s) moved to registered inspection location 2 New Street Square London EC4A 3BZ | |
29 Nov 2024 | AD02 | Register inspection address has been changed from 1 Kingdom Street London W2 6BD United Kingdom to 2 New Street Square London EC4A 3BZ | |
10 Jul 2024 | CS01 | Confirmation statement made on 28 June 2024 with no updates | |
07 Apr 2024 | AA | Full accounts made up to 31 March 2023 | |
19 Feb 2024 | CH01 | Director's details changed for Ms Seyda Atadan Memis on 1 September 2023 | |
17 Jul 2023 | AA | Full accounts made up to 31 March 2022 | |
07 Jul 2023 | CS01 | Confirmation statement made on 28 June 2023 with updates | |
10 Jun 2023 | DISS40 | Compulsory strike-off action has been discontinued | |
06 Jun 2023 | GAZ1 | First Gazette notice for compulsory strike-off | |
02 Jun 2023 | TM02 | Termination of appointment of Takeda Corporate Services Limited as a secretary on 31 May 2023 | |
26 Jan 2023 | TM01 | Termination of appointment of Jonathan Clark Neal as a director on 18 January 2023 | |
10 Nov 2022 | TM01 | Termination of appointment of Mark Gibbons as a director on 8 November 2022 | |
23 Aug 2022 | AP01 | Appointment of Ms Seyda Atadan Memis as a director on 1 August 2022 | |
04 Jul 2022 | CS01 | Confirmation statement made on 28 June 2022 with updates | |
18 May 2022 | AA | Full accounts made up to 1 April 2021 | |
21 Mar 2022 | AP01 | Appointment of Peter Michael Grubin as a director on 1 March 2022 | |
21 Mar 2022 | TM01 | Termination of appointment of Kentaro Shirahata as a director on 1 March 2022 | |
09 Jul 2021 | CS01 | Confirmation statement made on 28 June 2021 with updates | |
15 Mar 2021 | SH20 | Statement by Directors | |
15 Mar 2021 | SH19 |
Statement of capital on 15 March 2021
|
|
15 Mar 2021 | CAP-SS | Solvency Statement dated 08/03/21 | |
15 Mar 2021 | RESOLUTIONS |
Resolutions
|
|
11 Mar 2021 | AA01 | Current accounting period extended from 31 December 2020 to 31 March 2021 | |
30 Nov 2020 | AP01 | Appointment of Mr Kentaro Shirahata as a director on 30 November 2020 |